The Limited Times

Now you can see non-English news...

Medicines: manufacturing in France, strategic stocks... what the new anti-shortage plan contains

2024-02-21T13:44:51.309Z

Highlights: Medicines: manufacturing in France, strategic stocks... what the new anti-shortage plan contains. A “road map’ to “improve patient access to medicines and information in complete transparency” will be presented. Nearly 5,000 reports of shortages or risks of stock shortages of a medication were reported last year, an increase of 31% compared to 2022. Amoxicillin, Quasym, Tercian, Ozempic …many molecules were missing from pharmacies.


EXCLUSIVE. A “road map” to “improve patient access to medicines and information in complete transparency” will be


Nearly 5,000 reports of shortages or risks of stock shortages of a medication were reported last year, an increase of 31% compared to 2022 and 123% compared to 2021. Amoxicillin, Quasym, Tercian, Ozempic …many molecules were missing from pharmacies.

To stop the phenomenon, Catherine Vautrin, the Minister of Labor and Health, presents this Wednesday February 21, with the Minister Delegate for Health Frédéric Valletoux and his counterpart in Industry Roland Lescure, their anti-shortages plan.

Measures for 2024-2027 that the Parisian - Today in France was able to consult in preview.

The new plan, which extends the system put in place from 2019, is built on four pillars: “Innovate, produce, treat and prescribe, and finally deliver”.

“We put all the players around the table and we point out what worked or not to improve things,” argues Roland Lescure.

Subscribe

Already subscribed?

To log in

Source: leparis

All life articles on 2024-02-21

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.